5 completed. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
Follow fasudil: new trials by email Literature Review of fasudil trials Research Report on fasudil
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability and Symptomatic Efficacy of the ROCK-Inhibitor Fasudil in Patients With Parkinson's Disease Fasudil hydrochloride, Placebo - Idiopathic Parkinson´s Disease | Phase 2 | Completed | Technical University of Munich | 81 | 2023-09-11 | 2026-09-11 |
| Fasudil fOr redUcing elopemeNt and Spatial Disorientation Oral Fasudil 90 mg/day, Oral Fasudil 180 mg/day, Oral Placebo - Dementia | Phase 2 | Completed | Woolsey Pharmaceuticals | 24 | 2020-12-15 | 2022-07-11 |
| Inhibition of Rho Kinase (ROCK) With Fasudil as Disease-modifying Treatment for ALS Fasudil, Placebo - Amyotrophic Lateral Sclerosis | Phase 2 | Completed | University Medical Center Goettingen | 120 | 2019-02-20 | 2023-11-30 |
| Red Blood Cell ATP Release and Vascular Function in Humans Fasudil Hydrochloride, Saline - Cardiovascular Diseases | Phase 2 | Completed | Colorado State University | 31 | 2017-07-14 | 2020-02-27 |
| The Effect of Fasudil on Vascular Function in Humans fasudil - Atherosclerosis, Hypercholesterolemia | Phase 2 | Completed | Brigham and Women's Hospital | 60 | 2002-06-01 | 2008-09-30 |
Amyotrophic Lateral Sclerosis (1) · Atherosclerosis (1) · Cardiovascular Diseases (1) · Dementia (1) · Hypercholesterolemia (1) · Motor Neuron Disease (1) · Neurodegenerative Diseases (1) · Wandering Behavior (1)
Brigham and Women's Hospital (1) · Colorado State University (1) · Technical University of Munich (1) · University Medical Center Goettingen (1) · Woolsey Pharmaceuticals (1)
United States (3) · Germany (2) · Australia (1) · France (1) · Switzerland (1)
Frank Dinenno, PhD (1) · Mark A Creager, MD (1) · Paul Lingor, MD (1)
PMID 33533663, PMID 38419648, PMID 39424560, PMID 42235092
2017 (1)